nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TUBA4A—hindbrain—Parkinson's disease	0.0248	0.112	CbGeAlD
Podofilox—Etoposide—GSTP1—Parkinson's disease	0.0219	0.561	CrCbGaD
Podofilox—TUBA4A—brainstem—Parkinson's disease	0.0142	0.0645	CbGeAlD
Podofilox—TUBA4A—forebrain—Parkinson's disease	0.0137	0.0622	CbGeAlD
Podofilox—TUBA4A—cardiovascular system—Parkinson's disease	0.0116	0.0526	CbGeAlD
Podofilox—NR3C1—nerve—Parkinson's disease	0.0112	0.051	CbGeAlD
Podofilox—Etoposide—CYP2E1—Parkinson's disease	0.0112	0.288	CrCbGaD
Podofilox—TUBA4A—medulla oblongata—Parkinson's disease	0.00991	0.0449	CbGeAlD
Podofilox—TUBA4A—midbrain—Parkinson's disease	0.00906	0.0411	CbGeAlD
Podofilox—TUBA4A—spinal cord—Parkinson's disease	0.00884	0.0401	CbGeAlD
Podofilox—NR3C1—hindbrain—Parkinson's disease	0.00842	0.0382	CbGeAlD
Podofilox—TUBA4A—head—Parkinson's disease	0.00785	0.0356	CbGeAlD
Podofilox—TUBA4A—G2/M Transition—DCTN1—Parkinson's disease	0.0075	0.0101	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.00745	0.0101	CbGpPWpGaD
Podofilox—TUBA4A—nervous system—Parkinson's disease	0.00745	0.0338	CbGeAlD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—DGKQ—Parkinson's disease	0.00744	0.01	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—DCTN1—Parkinson's disease	0.0074	0.00999	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—INSR—Parkinson's disease	0.00738	0.00997	CbGpPWpGaD
Podofilox—TUBB—medulla oblongata—Parkinson's disease	0.00727	0.0329	CbGeAlD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—HSPA8—Parkinson's disease	0.00719	0.0097	CbGpPWpGaD
Podofilox—TUBA4A—central nervous system—Parkinson's disease	0.00717	0.0325	CbGeAlD
Podofilox—TUBA4A—cerebellum—Parkinson's disease	0.00701	0.0318	CbGeAlD
Podofilox—TUBA4A—Platelet degranulation—FGB—Parkinson's disease	0.00682	0.00921	CbGpPWpGaD
Podofilox—TUBB—midbrain—Parkinson's disease	0.00664	0.0301	CbGeAlD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—Parkinson's disease	0.0066	0.00892	CbGpPWpGaD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—Parkinson's disease	0.00654	0.00883	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—ABL1—Parkinson's disease	0.00652	0.0088	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—FGB—Parkinson's disease	0.00649	0.00877	CbGpPWpGaD
Podofilox—TUBB—spinal cord—Parkinson's disease	0.00648	0.0294	CbGeAlD
Podofilox—CYP2C19—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.00643	0.00868	CbGpPWpGaD
Podofilox—TUBB—G2/M Transition—DCTN1—Parkinson's disease	0.00638	0.00861	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—DCTN1—Parkinson's disease	0.00629	0.00849	CbGpPWpGaD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—HSPA8—Parkinson's disease	0.00611	0.00825	CbGpPWpGaD
Podofilox—CYP2C19—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00588	0.00794	CbGpPWpGaD
Podofilox—Etoposide—ABCB1—Parkinson's disease	0.00588	0.151	CrCbGaD
Podofilox—TUBA4A—brain—Parkinson's disease	0.00569	0.0258	CbGeAlD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—Parkinson's disease	0.00556	0.00751	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—ABL1—Parkinson's disease	0.00554	0.00748	CbGpPWpGaD
Podofilox—NR3C1—embryo—Parkinson's disease	0.00527	0.0239	CbGeAlD
Podofilox—TUBB—cerebellum—Parkinson's disease	0.00514	0.0233	CbGeAlD
Podofilox—TUBA4A—Platelet degranulation—SOD1—Parkinson's disease	0.00506	0.00683	CbGpPWpGaD
Podofilox—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00499	0.00673	CbGpPWpGaD
Podofilox—NR3C1—brainstem—Parkinson's disease	0.00483	0.0219	CbGeAlD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.00482	0.00651	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—IGF2—Parkinson's disease	0.00481	0.00649	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00473	0.00639	CbGpPWpGaD
Podofilox—NR3C1—forebrain—Parkinson's disease	0.00466	0.0211	CbGeAlD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.00458	0.00618	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—HGF—Parkinson's disease	0.00454	0.00613	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PENK—Parkinson's disease	0.00438	0.00592	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.00432	0.00584	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MERTK—Parkinson's disease	0.0043	0.00581	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—DOCK3—Parkinson's disease	0.0043	0.00581	CbGpPWpGaD
Podofilox—TUBB—brain—Parkinson's disease	0.00417	0.0189	CbGeAlD
Podofilox—CYP2C19—Xenobiotics—CYP2D6—Parkinson's disease	0.00398	0.00538	CbGpPWpGaD
Podofilox—NR3C1—cardiovascular system—Parkinson's disease	0.00394	0.0179	CbGeAlD
Podofilox—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.00392	0.00529	CbGpPWpGaD
Podofilox—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00385	0.00519	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—DGKQ—Parkinson's disease	0.00384	0.00518	CbGpPWpGaD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00383	0.00517	CbGpPWpGaD
Podofilox—CYP2C19—Xenobiotics—CYP2E1—Parkinson's disease	0.00364	0.00492	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00358	0.00484	CbGpPWpGaD
Podofilox—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00356	0.00481	CbGpPWpGaD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.0035	0.00473	CbGpPWpGaD
Podofilox—NR3C1—medulla oblongata—Parkinson's disease	0.00337	0.0153	CbGeAlD
Podofilox—NR3C1—midbrain—Parkinson's disease	0.00308	0.0139	CbGeAlD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00302	0.00408	CbGpPWpGaD
Podofilox—NR3C1—spinal cord—Parkinson's disease	0.003	0.0136	CbGeAlD
Podofilox—TOP2A—Circadian rythm related genes—DDC—Parkinson's disease	0.00298	0.00402	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00296	0.004	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—HSPA9—Parkinson's disease	0.00288	0.00389	CbGpPWpGaD
Podofilox—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00286	0.00387	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00286	0.00386	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—Parkinson's disease	0.00269	0.00363	CbGpPWpGaD
Podofilox—NR3C1—head—Parkinson's disease	0.00267	0.0121	CbGeAlD
Podofilox—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00262	0.00354	CbGpPWpGaD
Podofilox—NR3C1—nervous system—Parkinson's disease	0.00253	0.0115	CbGeAlD
Podofilox—TUBA4A—Hemostasis—MAG—Parkinson's disease	0.00247	0.00334	CbGpPWpGaD
Podofilox—NR3C1—central nervous system—Parkinson's disease	0.00243	0.011	CbGeAlD
Podofilox—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.0024	0.00323	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.00239	0.00322	CbGpPWpGaD
Podofilox—NR3C1—cerebellum—Parkinson's disease	0.00238	0.0108	CbGeAlD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00237	0.0032	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TH—Parkinson's disease	0.00237	0.0032	CbGpPWpGaD
Podofilox—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00236	0.00318	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00233	0.00315	CbGpPWpGaD
Podofilox—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.0023	0.00311	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.00225	0.00303	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00224	0.00302	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Parkinson's disease	0.00224	0.00302	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00223	0.00301	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00222	0.003	CbGpPWpGaD
Podofilox—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00219	0.00296	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—DCTN1—Parkinson's disease	0.00213	0.00288	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.00213	0.00288	CbGpPWpGaD
Podofilox—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00211	0.00285	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00207	0.0028	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—RPL6—Parkinson's disease	0.00205	0.00277	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.00203	0.00274	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.00201	0.00272	CbGpPWpGaD
Podofilox—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00197	0.00267	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00197	0.00266	CbGpPWpGaD
Podofilox—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00195	0.00264	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00195	0.00263	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00194	0.00263	CbGpPWpGaD
Podofilox—NR3C1—brain—Parkinson's disease	0.00193	0.00877	CbGeAlD
Podofilox—CYP3A4—nervous system—Parkinson's disease	0.00191	0.00867	CbGeAlD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00188	0.00253	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—DRD1—Parkinson's disease	0.00186	0.00252	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00186	0.00252	CbGpPWpGaD
Podofilox—CYP3A4—central nervous system—Parkinson's disease	0.00184	0.00835	CbGeAlD
Podofilox—TUBB—Cell Cycle—DCTN1—Parkinson's disease	0.00181	0.00245	CbGpPWpGaD
Podofilox—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00181	0.00244	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—DRD3—Parkinson's disease	0.00181	0.00244	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0018	0.00244	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—DCTN1—Parkinson's disease	0.00178	0.0024	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—Parkinson's disease	0.00177	0.00239	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00169	0.00228	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TH—Parkinson's disease	0.00166	0.00224	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00166	0.00224	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00165	0.00223	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—DRD2—Parkinson's disease	0.00163	0.0022	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—HTR7—Parkinson's disease	0.00163	0.0022	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00163	0.0022	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—FGB—Parkinson's disease	0.00156	0.0021	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—RPL23A—Parkinson's disease	0.00155	0.0021	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—RPL14—Parkinson's disease	0.00155	0.0021	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00151	0.00204	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00151	0.00203	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00149	0.00202	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—RPS8—Parkinson's disease	0.00145	0.00196	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00145	0.00196	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00143	0.00194	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00143	0.00193	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IL6—Parkinson's disease	0.00143	0.00193	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00143	0.00193	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.00142	0.00192	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00141	0.0019	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00139	0.00187	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00134	0.00181	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00129	0.00174	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00127	0.00172	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—DCTN1—Parkinson's disease	0.00127	0.00171	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00125	0.00169	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00125	0.00168	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00123	0.00166	CbGpPWpGaD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00117	0.00159	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SOD1—Parkinson's disease	0.00116	0.00156	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00113	0.00152	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00112	0.00151	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00111	0.00149	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ABL1—Parkinson's disease	0.0011	0.00149	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IGF2—Parkinson's disease	0.0011	0.00148	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00108	0.00147	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00108	0.00145	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00106	0.00143	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00105	0.00142	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HGF—Parkinson's disease	0.00104	0.0014	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00102	0.00137	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00101	0.00136	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000995	0.00134	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000982	0.00133	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000958	0.00129	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00091	0.00123	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000902	0.00122	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000898	0.00121	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PRKRA—Parkinson's disease	0.00088	0.00119	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF2—Parkinson's disease	0.000865	0.00117	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000858	0.00116	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000806	0.00109	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—INS—Parkinson's disease	0.000789	0.00107	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	0.00078	0.00105	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000737	0.000996	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000712	0.000962	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000704	0.000951	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000702	0.000949	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000651	0.00088	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000647	0.000874	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000647	0.000873	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000642	0.000868	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000638	0.000861	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000621	0.000839	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—TAF1—Parkinson's disease	0.00062	0.000837	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR4A2—Parkinson's disease	0.00062	0.000837	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000607	0.000819	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000596	0.000804	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00058	0.000784	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000576	0.000778	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—INS—Parkinson's disease	0.000574	0.000775	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000566	0.000764	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.00054	0.000729	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000537	0.000725	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000536	0.000724	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000532	0.000719	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00053	0.000716	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000512	0.000692	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000509	0.000687	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000508	0.000685	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.000498	0.000673	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPL6—Parkinson's disease	0.000496	0.000669	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000494	0.000667	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000487	0.000658	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000428	0.000578	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—Parkinson's disease	0.000427	0.000577	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000422	0.00057	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—Parkinson's disease	0.000397	0.000536	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000392	0.000529	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000386	0.000522	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPL14—Parkinson's disease	0.000376	0.000507	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPL23A—Parkinson's disease	0.000376	0.000507	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000372	0.000502	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000369	0.000498	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPS8—Parkinson's disease	0.00035	0.000473	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ND3—Parkinson's disease	0.00035	0.000473	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.00035	0.000473	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—Parkinson's disease	0.000345	0.000465	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000329	0.000444	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000329	0.000444	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000325	0.000438	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000323	0.000436	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000322	0.000435	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.00032	0.000432	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000319	0.00043	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000312	0.000421	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000298	0.000402	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000298	0.000402	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000297	0.000401	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000293	0.000395	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA8—Parkinson's disease	0.000281	0.000379	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—CTGF—Parkinson's disease	0.000279	0.000377	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000268	0.000363	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000265	0.000358	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000265	0.000358	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000265	0.000358	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	0.000255	0.000345	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.00021	0.000284	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ND3—Parkinson's disease	0.00021	0.000284	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000198	0.000267	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000198	0.000267	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000195	0.000263	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000188	0.000253	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000184	0.000248	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000182	0.000245	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000179	0.000242	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000166	0.000224	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000164	0.000221	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GBA—Parkinson's disease	0.00016	0.000215	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.00016	0.000215	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DBH—Parkinson's disease	0.00016	0.000215	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000156	0.000211	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.000122	0.000164	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.00012	0.000161	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000117	0.000158	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000111	0.00015	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000111	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.00011	0.000149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TH—Parkinson's disease	0.000109	0.000147	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.000104	0.000141	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.96e-05	0.000134	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MAOB—Parkinson's disease	9.86e-05	0.000133	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COMT—Parkinson's disease	9.23e-05	0.000125	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTP1—Parkinson's disease	9.19e-05	0.000124	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MAOA—Parkinson's disease	9.17e-05	0.000124	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HMOX1—Parkinson's disease	9.06e-05	0.000122	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—Parkinson's disease	8.7e-05	0.000117	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GSTM1—Parkinson's disease	8.44e-05	0.000114	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX1—Parkinson's disease	8.09e-05	0.000109	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—Parkinson's disease	7.46e-05	0.000101	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	7.32e-05	9.89e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CTGF—Parkinson's disease	7.19e-05	9.71e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—Parkinson's disease	6.95e-05	9.38e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.7e-05	9.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.62e-05	8.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TH—Parkinson's disease	6.53e-05	8.82e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYCS—Parkinson's disease	6.27e-05	8.46e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—INS—Parkinson's disease	5.93e-05	8.01e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COMT—Parkinson's disease	5.55e-05	7.5e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.52e-05	7.46e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MAOA—Parkinson's disease	5.51e-05	7.44e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HMOX1—Parkinson's disease	5.45e-05	7.36e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.23e-05	7.06e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.08e-05	6.86e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.86e-05	6.57e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.49e-05	6.06e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—Parkinson's disease	4.18e-05	5.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—INS—Parkinson's disease	3.57e-05	4.82e-05	CbGpPWpGaD
